[LXRX] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
01-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -0.48%
YoY- 8.01%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 9,163 9,682 13,753 12,053 20,089 376 676 54.35%
PBT -69,071 -23,018 -34,706 -35,059 -38,112 -28,074 -26,028 17.64%
Tax 5,125 -219 6,097 2,062 1,638 1,655 435 50.78%
NP -69,071 -23,018 -34,706 -35,059 -38,112 -28,074 -26,028 17.64%
Tax Rate - - - - - - - -
Total Cost 78,234 32,700 48,459 47,112 58,201 28,450 26,704 19.60%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin -753.80 -237.74 -252.35 -290.87 -189.72 -7,466.49 -3,850.30 -23.78%
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS -0.65 -0.22 -0.33 -0.33 -0.37 -0.27 -0.35 10.85%
EPS Diluted -0.65 -0.22 -0.33 -0.33 -0.37 -0.27 -0.35 10.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.